Get started
Author

Lucy Coleman

Observed names: COLEMAN, LUCY, Coleman, Lucy
ORCID: 0000-0001-9036-1317
Observed ORCID: 0000-0001-9036-1317
OpenAlex ID: A5103257554
Antibiotics-Free Compounds for Chronic Wound Healing
2022 · David O. Oluwole, Lucy Coleman, et al. · Pharmaceutics · 39
PDF
Systematic review and QSPR analysis of chemical penetration through the nail to inform onychomycosis candidate selection
2023 · Osamah S. Malallah, Lucy Coleman, et al. · Drug Discovery Today · 8
In Silico Simulation of Simultaneous Percutaneous Absorption and Xenobiotic Metabolism: Model Development and a Case Study on Aromatic Amines
2020 · Lucy Coleman, Guoping Lian, et al. · Pharmaceutical Research · 8
Non-Antibiotic Compounds Synergistically Kill Chronic Wound-Associated Bacteria and Disrupt Their Biofilms
2023 · Lucy Coleman, James R. G. Adams, et al. · Pharmaceutics · 7
PDF
Development and Implementation of a Hinderance-based In Vitro Model for Porous Membranes
2026 · Daniel A. Paterson, Lucy Coleman, et al. · The AAPS Journal · 1
Physiologically based pharmacokinetic modelling facilitates prediction of clobetasol propionate skin permeation enhancement in vitro: a propylene glycol case study
2026 · Dancik, Yuri, Tabosa, Alice, et al. · Mendeley Data
Dermal PBPK modelling of clobetasol propionate cream: Guiding IVPT design and assessing the impact of globule size on skin permeation
2026 · Zhang, Yanling, Murthy, S. Narasimha, et al. · Mendeley Data
Works count: 8
Citation count: 63
H-index: 4
I10-index: 1
Year
Topic
Type